Gene transfer to mammalian cells using genetically targeted filamentous bacteriophage

We have genetically modified filamentous bacteriophage to deliver genes to mammalian cells. In previous studies we showed that noncovalently attached fibroblast growth factor (FGF2) can target bacteriophage to COS‐1 cells, resulting in receptor‐mediated transduction with a reporter gene. Thus, bacteriophage, which normally lack tropism for mammalian cells, can be adapted for mammalian cell gene transfer. To determine the potential of using phage‐mediated gene transfer as a novel display phage screening strategy, we transfected COS‐1 cells with phage that were engineered to display FGF2 on their surface coat as a fusion to the minor coat protein, pIII. Immunoblot and ELISA analysis confirmed the presence of FGF2 on the phage coat. Significant transduction was obtained in COS‐1 cells with the targeted FGF2‐phage compared with the nontargeted parent phage. Specificity was demonstrated by successful inhibition of transduction in the presence of excess free FGF2. Having demonstrated mammalian cell transduction by phage displaying a known gene targeting ligand, it is now feasible to apply phage‐mediated transduction as a screen for discovering novel ligands.—Larocca, D., Kassner, P. D., Witte, A., Ladner, R. C., Pierce, G., Baird, A. Gene transfer to mammalian cells using genetically targeted filamentous bacteriophage. FASEB J. 13, 727–734 (1999)

[1]  G. Pierce,et al.  Targeting bacteriophage to mammalian cell surface receptors for gene delivery. , 1998, Human gene therapy.

[2]  D. Curiel,et al.  Enhanced in vivo gene delivery to human ovarian cancer xenografts utilizing a tropism-modified adenovirus vector , 1998 .

[3]  G. Chinea,et al.  Displaying human interleukin-2 on the surface of bacteriophage. , 1997, Immunotechnology : an international journal of immunological engineering.

[4]  E. Rowold,et al.  Phage presentation and affinity selection of a deletion mutant of human lnterleukin-3 , 1997, Applied biochemistry and biotechnology.

[5]  G. Waksman,et al.  Heparin-induced Self-association of Fibroblast Growth Factor-2 , 1997, The Journal of Biological Chemistry.

[6]  D. Curiel,et al.  Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor. , 1997, Cancer research.

[7]  M. Lefranc,et al.  A simple luciferase assay for signal transduction activity detection of epidermal growth factor displayed on phage. , 1997, Nucleic acids research.

[8]  T. Ciardelli,et al.  The functional display of interleukin-2 on filamentous phage. , 1997, Archives of biochemistry and biophysics.

[9]  Y. Buechler,et al.  Targeting DNA to Cells with Basic Fibroblast Growth Factor (FGF2)* , 1996, The Journal of Biological Chemistry.

[10]  Erkki Ruoslahti,et al.  Organ targeting In vivo using phage display peptide libraries , 1996, Nature.

[11]  William J. Dower,et al.  Toward cell–targeting gene therapy vectors: Selection of cell–binding peptides from random peptide–presenting phage libraries , 1996, Nature Medicine.

[12]  C. Hodgson.  The Vector Void in Gene Therapy , 1995, Bio/Technology.

[13]  R. Laufer,et al.  Functional phage display of ciliary neurotrophic factor. , 1995, Gene.

[14]  S. Kato,et al.  Recombinant f1 phage-mediated transfection of mammalian cells using lipopolyamine technique. , 1994, Analytical Biochemistry.

[15]  Curiel Dt,et al.  Strategies to achieve targeted gene delivery via the receptor-mediated endocytosis pathway. , 1994, Gene therapy.

[16]  S. Hart,et al.  Cell binding and internalization by filamentous phage displaying a cyclic Arg-Gly-Asp-containing peptide. , 1994, The Journal of biological chemistry.

[17]  R. Matsunami,et al.  Reducing the heterogeneity of chemically conjugated targeted toxins: homogeneous basic FGF-saporin. , 1993, Analytical biochemistry.

[18]  D. Glück,et al.  Phage display as a rapid gene expression system: production of bioactive cytokine-phage and generation of neutralizing monoclonal antibodies. , 1993, Journal of immunological methods.

[19]  S. Kato,et al.  Recombinant f1 phage particles can transfect monkey COS-7 cells by DEAE dextran method. , 1993, Biochemical and biophysical research communications.

[20]  T. Arakawa,et al.  Production, biological activity, and structure of recombinant basic fibroblast growth factor and an analog with cysteine replaced by serine. , 1988, The Journal of biological chemistry.

[21]  H. Okayama,et al.  Bacteriophage lambda vector for transducing a cDNA clone library into mammalian cells , 1985, Molecular and cellular biology.

[22]  M. Ishiura,et al.  Phage Particle-Mediated Gene Transfer to Cultured Mammalian Cells , 1982, Molecular and cellular biology.

[23]  K. Beyreuther,et al.  Gene transfer to human cells: transducing phage lambda plac gene expression in GMI-gangliosidosis fibroblasts. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[24]  I. S. Dunn.  Mammalian cell binding and transfection mediated by surface-modified bacteriophage lambda. , 1996, Biochimie.

[25]  John McCafferty,et al.  Phage display of peptides and proteins : a laboratory manual , 1996 .

[26]  S Falkow,et al.  FACS-optimized mutants of the green fluorescent protein (GFP). , 1996, Gene.

[27]  D. Curiel,et al.  Strategies to achieve targeted gene delivery via the receptor-mediated endocytosis pathway. , 1994, Gene therapy.

[28]  J. Wells,et al.  Hormone phage: An enrichment method for variant proteins with altered binding properties , 1990, Proteins.